Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 1/20 | 0.53 |
| ▸ | LIPG | Q9Y5X9 | 8/20 | 0.50 |
| ▸ | LPL | P06858 | 7/20 | 0.50 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.43 |
| ▸ | KDR | P35968 | 2/20 | 0.43 |
| ▸ | LDHA | P00338 | 2/20 | 0.36 |
| ▸ | HPGDS | O60760 | 2/20 | 0.36 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.35 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.35 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.35 |
| ▸ | P4HB | P07237 | 1/20 | 0.34 |
| ▸ | DHODH | Q02127 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21390525 | 0.94 | LIPG (0.50) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL19933637 | 0.94 | LIPG (0.56) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL20696492 | 0.93 | DGAT1 (0.47) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL21390496 | 0.89 | DGAT1 (0.43) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL21202827 | 0.89 | DGAT1 (0.43) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL19834881 | 0.88 | DGAT1 (0.45) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL21142342 | 0.88 | DGAT1 (0.48) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL19933719 | 0.87 | DGAT1 (0.49) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL19794357 | 0.86 | LIPG (0.46) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL19933611 | 0.86 | DGAT1 (0.43) | DGAT1LIPGLPLPDGFRBKDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230320191-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2023-10-05 | — | — | US | disclosed |
| US-20230320191-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2023-10-05 | — | — | US | disclosed |
| US-11659763-B2 | Metal complexes | MERCK PATENT GMBH | 2023-05-23 | — | — | US | disclosed |
| US-11659763-B2 | Metal complexes | MERCK PATENT GMBH | 2023-05-23 | — | — | US | disclosed |
| US-11535640-B2 | Metal complexes | MERCK PATENT GMBH (DE) | 2022-12-27 | — | — | US | disclosed |
| EP-3487865-B1 | DINUCLEAR AND OLIGONUCLEAR METAL COMPLEXES CONTAINING TRIPODAL BIDENTATE PART LIGANDS AND THEIR USE IN ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2022-11-23 | — | — | EP | disclosed |
| EP-3601304-B1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2021-10-27 | — | — | EP | disclosed |
| US-11136343-B2 | Binuclear metal complexes for use as emitters in organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2021-10-05 | — | — | US | disclosed |
| US-20210175441-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2021-06-10 | — | — | US | disclosed |
| US-11024815-B2 | Metal complexes | MERCK PATENT GMBH (DE) | 2021-06-01 | — | — | US | disclosed |
| EP-3254317-B1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2019-07-31 | — | — | EP | disclosed |
| US-20190202851-A1 | BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2019-07-04 | — | — | US | disclosed |
| WO-2019115423-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2019-06-20 | — | — | WO | disclosed |
| US-20190157578-A1 | DINUCLEAR AND OLIGONUCLEAR METAL COMPLEXES CONTAINING TRIPODAL BIDENTATE PART LIGANDS AND THEIR USE IN ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2019-05-23 | — | — | US | disclosed |
| WO-2019020538-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2019-01-31 | — | — | WO | disclosed |
| WO-2018069196-A1 | BINUCLEAR METAL COMPLEXES AND ELECTRONIC DEVICES, IN PARTICULAR ORGANIC ELECTROLUMINESCENT DEVICES CONTAINING SAID METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2018-04-19 | — | — | WO | disclosed |
| WO-2018054798-A1 | BINUCLEAR METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2018-03-29 | — | — | WO | disclosed |
| WO-2018041769-A1 | BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2018-03-08 | — | — | WO | disclosed |
| US-20180026209-A1 | Metal Complexes | MERCK PATENT GMBH (DE) | 2018-01-25 | — | — | US | disclosed |
| US-20180026209-A1 | Metal Complexes | MERCK PATENT GMBH (DE) | 2018-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190202851-A1 | BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES | PARN, PUF60, PARG | DGAT1 2586/4885LIPG 4374/4885LPL 4558/4885 |
| US-11024815-B2 | Metal complexes | EXOC4, EXOC3, TIMCC | DGAT1 1835/4885LIPG 4459/4885LPL 4682/4885 |
| US-20190157578-A1 | DINUCLEAR AND OLIGONUCLEAR METAL COMPLEXES CONTAINING TRIPODAL BIDENTATE PART LIGANDS AND THEIR USE IN ELECTRONIC DEVICES | SSBP1, POLRMT, BICRA | DGAT1 3299/4885LIPG 4455/4885LPL 4791/4885 |
| US-20230320191-A1 | METAL COMPLEXES | IMMT, MCU, SOD1 | DGAT1 1413/4885LIPG 3702/4885LPL 3959/4885 |
| US-20210175441-A1 | METAL COMPLEXES | IMMT, MCU, SOD1 | DGAT1 1413/4885LIPG 3702/4885LPL 3959/4885 |
| US-20180026209-A1 | Metal Complexes | AP3M1, AP2M1, SOD1 | DGAT1 1328/4885LIPG 3693/4885LPL 3416/4885 |
| US-11535640-B2 | Metal complexes | IMMT, MCU, SOD1 | DGAT1 1413/4885LIPG 3702/4885LPL 3959/4885 |
| US-11659763-B2 | Metal complexes | IMMT, MCU, SOD1 | DGAT1 1413/4885LIPG 3702/4885LPL 3959/4885 |
| US-11136343-B2 | Binuclear metal complexes for use as emitters in organic electroluminescent devices | AP2M1, MCU, AP3M1 | DGAT1 1147/4885LIPG 3438/4885LPL 3633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.